In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abiomed Inc.

www.abiomed.com

Latest From Abiomed Inc.

After AdvaMed, Yared Takes Helm Of MDIC Board

CVRx CEO Nadim Yared has moved up on the board of directors at the Medical Device Innovation Consortium as its new chair. The public-private partnership group that formed in 2012 has been effective in working with the US Food and Drug Administration to develop new regulations.

Regulation Lobbying

FDA Says Abiomed’s Impella RP Pump Works For ‘Appropriate Patients’

In a letter sent 21 May, the US FDA tells physicians the benefits of Abiomed’s Impella RP right-heart circulatory support device outweigh the risks in appropriately selected patients. In February, the agency warned doctors that the postmarket study of the device showed worse survival than the premarket clinical trial.

FDA Safety

Global Device Approvals, Weekly Snapshot: Teleflex, Abiomed Gain Cardio Approvals

A snapshot of global device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, Teleflex's recently acquired Essential Medical business gained US approval for a closely watched vascular closure device and Abiomed gained a CE mark for a remote monitoring technology.

Into 2019: Meaningful Innovation In Medtech Is Reaching A 10-Year Peak

Medtech continues to outperform biotech from a sustainable investment growth point of view, and meanwhile medtech CEOs are on message about advancing value- and outcomes-based models with their provider partners. It all points to medtech being in a good place for 2019, and there is no reason for M&A and industry consolidation to stop anytime soon, says Jefferies equity analyst Raj Denhoy.

Financing M & A
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abiomed Inc.
  • Senior Management
  • Michael R Minogue, Pres. & CEO
    Todd A Trapp, CFO
    Michael Howley, VP, General Mgr., Global Sales
    Seth Bilazarian, MD, CMO
    David Weber, COO
  • Contact Info
  • Abiomed Inc.
    Phone: (508) 777-5410
    22 Cherry Hill Dr.
    Danvers, MA 01923
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register